Gürkov Robert, Todt Ingo, Jadeed Rawad, Sudhoff Holger, Gehl Hans-Björn
Department of Otorhinolaryngology Head and Neck Surgery.
Institute for Diagnostic Radiology, University Hospital Bielefeld, Bielefeld, Germany.
Otol Neurotol. 2020 Oct;41(9):e1140-e1144. doi: 10.1097/MAO.0000000000002775.
For clinical confirmation of the diagnosis of hydropic ear disease (HED) (Menière) by MR imaging, two routes of contrast enhancement of the perilymphatic space are currently being used: intratympanic and intravenous. While unilateral intratympanic contrast application generally enables a higher perilymph signal intensity and image quality, the intravenous route allows for imaging of both inner ears simultaneously. It is conceivable that intratympanic contrast application to one ear would result in a failure to detect endolymphatic hydrops in a given patient if the hydrops is present only in the other ear. Therefore, in this study we examined the question whether the ear with the greater degree of endolymphatic hydrops may be predicted based on clinical features.
Retrospective study of 50 patients with HED confirmed on MR imaging. Three tesla MR imaging with 3D fluid attenuated inversion recovery 4 hours after intravenous gadolinium contrast application was used to detect endolymphatic hydrops. The index ear was defined by auditory symptoms during attacks, low frequency hearing loss, and caloric canal paresis.
In all patients the ear with more severe symptoms corresponded with the ear showing the more severe hydrops on MR imaging.
In summary, in this study population the degree of low-frequency hearing loss (250 Hz-1 kHz) in combination with auditory symptoms during attacks identified the ear with the greater extent of endolymphatic hydrops in all patients. In conclusion, intratympanic contrast application to the index ear seems to be sufficient to confirm the diagnosis of HED (Menière) on MR imaging.
为通过磁共振成像(MR)对耳积水病(梅尼埃病)进行临床诊断确认,目前使用两种途径来增强内淋巴间隙的对比:鼓膜内注射和静脉注射。虽然单侧鼓膜内注射造影剂通常能使内淋巴信号强度和图像质量更高,但静脉注射途径可同时对双耳进行成像。可以想象,如果内淋巴积水仅存在于对侧耳中,那么对一侧耳进行鼓膜内注射造影剂可能会导致在特定患者中无法检测到内淋巴积水。因此,在本研究中,我们探讨了是否可以根据临床特征预测内淋巴积水程度较重的耳。
对50例经MR成像确诊为耳积水病的患者进行回顾性研究。静脉注射钆造影剂4小时后,采用3特斯拉MR成像和三维液体衰减反转恢复序列来检测内淋巴积水。患耳根据发作时的听觉症状、低频听力损失和冷热试验半规管轻瘫来定义。
在所有患者中,症状较重的耳与MR成像上显示积水更严重的耳相对应。
总之,在本研究人群中,低频听力损失程度(250赫兹至1千赫)与发作时的听觉症状相结合,可确定所有患者内淋巴积水程度较重的耳。总之,对患耳进行鼓膜内注射造影剂似乎足以在MR成像上确诊耳积水病(梅尼埃病)。